Literature DB >> 9649914

Depressive symptoms and Depo-Provera.

C Westhoff1, C Truman, D Kalmuss, L Cushman, A Davidson, M Rulin, S Heartwell.   

Abstract

Women enrolled in a multicenter prospective study were evaluated to identify any possible relationship between depressive symptoms and the use of contraceptives. Women choosing Depo-Provera (n = 495) were evaluated before starting these contraceptives and were reinterviewed 1 year later. Women who continued the method had lower depressive symptom scores at baseline than did the women who discontinued the method or who were lost to follow-up. Among the continuing Depo-Provera users, the depressive symptom scores improved slightly at 1 year (7.4 vs 6.7). Those subjects with the highest (i.e., worst) scores at enrollment demonstrated improved scores at follow-up.

Entities:  

Keywords:  Acceptors; Acceptors, New--women; Americas; Cohort Analysis; Contraception; Contraception Termination; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods--side effects; Depo-provera--side effects; Depression; Developed Countries; Diseases; Family Planning; Family Planning Programs; Injectables--side effects; Medroxyprogesterone Acetate--side effects; Mental Disorders; North America; Northern America; Prospective Studies; Research Methodology; Research Report; Studies; United States

Mesh:

Substances:

Year:  1998        PMID: 9649914     DOI: 10.1016/s0010-7824(98)00024-9

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  10 in total

Review 1.  Recent developments in hormonal contraception.

Authors:  Eleanor A Drey; Philip D Darney
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

Review 2.  Transdermal estradiol for postpartum depression: a promising treatment option.

Authors:  Eydie L Moses-Kolko; Sarah L Berga; Brinda Kalro; Dorothy K Y Sit; Katherine L Wisner
Journal:  Clin Obstet Gynecol       Date:  2009-09       Impact factor: 2.190

3.  Clinical Case Rounds in Child and Adolescent Psychiatry: De Novo Self-Mutilation and Depressive Symptoms in a 17-year-old Adolescent Girl Receiving Depot-Medroxyprogesterone Acetate.

Authors:  Martin St-André; Irena Stikarovska; Suzy Gascon
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2012-02

Review 4.  Progesterone, reproduction, and psychiatric illness.

Authors:  Lindsay R Standeven; Katherine O McEvoy; Lauren M Osborne
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2020-06-18       Impact factor: 5.237

Review 5.  Contraception and mental health: a commentary on the evidence and principles for practice.

Authors:  Kelli Stidham Hall; Julia R Steinberg; Carrie A Cwiak; Rebecca H Allen; Sheila M Marcus
Journal:  Am J Obstet Gynecol       Date:  2014-12-12       Impact factor: 8.661

6.  The association between depression and contraceptive behaviors in a diverse sample of new prescription contraception users.

Authors:  Deborah Quint Shelef; Tina Raine-Bennett; Malini Chandra; Nancy Adler; Cassondra J Marshall; Julia R Steinberg
Journal:  Contraception       Date:  2021-09-02       Impact factor: 3.375

7.  Psychological distress and post-abortion contraceptive method effectiveness level chosen at an urban clinic.

Authors:  Julia R Steinberg; Jeanne M Tschann; Jillian T Henderson; Eleanor A Drey; Jody E Steinauer; Cynthia C Harper
Journal:  Contraception       Date:  2013-09-09       Impact factor: 3.375

Review 8.  Hormonal contraception in adolescents: special considerations.

Authors:  Rollyn M Ornstein; Martin M Fisher
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

9.  Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.

Authors:  D Heather Watts; Jeong-Gun Park; Susan E Cohn; Song Yu; Jane Hitti; Alice Stek; Pamela A Clax; Laila Muderspach; Juan J L Lertora
Journal:  Contraception       Date:  2007-12-21       Impact factor: 3.375

10.  Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression.

Authors:  Elizabeth A Young; Susan G Kornstein; Anne T Harvey; Stephen R Wisniewski; Jennifer Barkin; Maurizio Fava; Madhukar H Trivedi; A John Rush
Journal:  Psychoneuroendocrinology       Date:  2007-07-16       Impact factor: 4.905

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.